Basiliximab in Moderate to Severe Ulcerative Colitis
Public ClinicalTrials.gov record NCT00430898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, With Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety, effectiveness and pharmacokinetics of two levels of intravenous basiliximab in ulcerative colitis, compared to placebo.
Study identification
- NCT ID
- NCT00430898
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Aug 31, 2008
- Completion
- Aug 31, 2008
- Last update posted
- Dec 17, 2008
2007 – 2008
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anaheim | California | — | — |
| Not listed | Roseville | California | 95661 | — |
| Not listed | Golden | Colorado | — | — |
| Not listed | Littleton | Colorado | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Urbana | Illinois | 61801 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Topeka | Kansas | 66606 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Troy | Michigan | — | — |
| Not listed | Egg Harbor Twp | New Jersey | 08234 | — |
| Not listed | Great Neck | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Fargo | North Dakota | 58104 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Sewickley | Pennsylvania | 15143 | — |
| Not listed | Germantown | Tennessee | — | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Galveston | Texas | — | — |
| Not listed | Houston | Texas | 77090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00430898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2008 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00430898 live on ClinicalTrials.gov.